Article Information
History
- January 11, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Riaz Gillani1,2,3,4,
- Sabrina Y. Camp2,5,
- Seunghun Han2,6,
- Jill K. Jones6,
- Schuyler O’Brien7,
- Erin L. Young7,
- Lucy Hayes7,
- Gareth Mitchell7,
- Trent Fowler7,
- Alexander Gusev5,8,
- Junne Kamihara1,3,4,
- Katherine A. Janeway1,2,3,4,
- Joshua D. Schiffman7,
- Brian D. Crompton1,2,3,4,*,
- Saud H. AlDubayan2,5,9,10,* and
- Eliezer M. Van Allen2,5,11,*
- 1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA
- 2Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA
- 3Department of Pediatrics, Harvard Medical School, Boston, MA 02215, USA
- 4Boston Children’s Hospital, Boston, MA 02115, USA
- 5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA
- 6Harvard Medical School, Boston, MA 02115, USA
- 7Huntsman Cancer Institute, 2000 Circle of Hope Dr, Room 4246, Salt Lake City, UT 84112
- 8Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
- 9Division of Genetics, Brigham and Women’s Hospital, Boston, MA 02115
- 10College of Medicine, King Saudi bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
- 11Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02115, USA
- ↵*Corresponding authors Brian D. Crompton, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, Email: briand_crompton{at}dfci.harvard.edu, Phone: 617-632-3000, Saud H. AlDubayan, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, Email: saud_aldubayan{at}dfci.harvard.edu, Phone: 617-632-3000, Eliezer M. Van Allen, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, Email: eliezerm_vanallen{at}dfci.harvard.edu, Phone: 617-632-3000
Posted January 11, 2022.
Germline predisposition to pediatric Ewing sarcoma is uniquely characterized by inherited pathogenic variants in DNA damage repair genes
